Results 21 to 30 of about 1,309,269 (176)

A Randomized Double-Blind Comparative Study of Sublingual Immunotherapy for Cedar Pollinosis [PDF]

Allergology International, 2008
Background: Seasonal allergic rhinitis (SAR) induced by Japanese cedar pollen is a substantial problem in Japan. Sublingual immuno-therapy (SLIT) is safer than conventional antigen-specific immunotherapy, the only treatment modality by which complete ...
Kimihiro Okubo, Minoru Gotoh, Shigeharu Fujieda, Mitsuhiro Okano, Hirokazu Yoshida, Hiroshi Morikawa, Keisuke Masuyama, Yoshitaka Okamoto, Makoto Kobayashi   +8 more
doaj   +2 more sources

Effects of Pranlukast Hydrate on Airway Hyperresponsiveness in Non-Asthmatic Patients with Japanese Cedar Pollinosis [PDF]

Allergology International, 2009
Background: Recent studies have suggested that allergic rhinitis is closely related to bronchial asthma, reflecting the "one airway-one disease" hypothesis.
Hironori Sagara, Tatsuo Yukawa, Ryuichi Kashima, Takenori Okada, Takeshi Fukuda   +4 more
doaj   +2 more sources

Real-world efficacy of sublingual immunotherapy with Japanese cedar pollen for cypress pollinosis [PDF]

Journal of Allergy and Clinical Immunology: Global
Background: It remains unclear whether allergen immunotherapy with Japanese cedar pollen extract is effective for Japanese cypress pollinosis in real-world settings. Objective: We sought to investigate the Japan-wide prevalence of cypress pollinosis, the
Aiko Oka, MD, Tamami Yamashita, MD, Kengo Kanai, MD, Atsushi Yuta, MD, Yukiko Ogawa, MD, Eriko Takahara, MD, Hideki Shiratsuchi, MD, Akihiko Terada, MD, Takatsugu Tsunoda, MD, Takeshi Masuda, MD, Satoru Masuno, MD, Kenichi Kanai, MD, Hitoshi Nagakura, MD, Reiko Tokuda, MD, Harumi Arao, MD, Hitoshi Bamba, MD, Shigenobu Yasuda, MD, Hideya Mimura, MD, Mahoko Nakazato, MD, Hidehisa Nakazato, MD, Noriyuki Houya, MD, Hideaki Tsuzuki, MD, Masaharu Tokuriki, MD, Mayuko Sakaida, MD, Ryo Amesara, MD, Chikahisa Ohkawa, MD, Takemitsu Hama, MD, Hiroki Ikeda, MD, Hisaki Fukushima, MD, Sumiko Niitsu, MD, Hirofumi Sakaguchi, MD, Norihito Iba, MD, Hiroshi Kumanomidou, MD, Yoshiyuki Hyo, MD, Ryo Takagi, MD, Takashi Koike, MD, Marie Yamada, MD, Mitsuhiro Okano, MD   +37 more
doaj   +2 more sources

Intake of a fermented plant product attenuates allergic symptoms without changing systemic immune responses in a mouse model of Japanese cedar pollinosis [PDF]

World Allergy Organization Journal, 2018
Background Japanese cedar pollinosis (JCP) is one of the most prevalent allergies in Japan. Within the past few decades, many food factors have been demonstrated to suppress symptoms of pollinosis and mast cell degranulation directly or indirectly ...
Takashi Fujimura, Ayane Hori, Hideto Torii, Shinsuke Kishida, Yoshinori Matsuura, Seiji Kawamoto   +5 more
doaj   +2 more sources

Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber) [PDF]

Allergology International, 2017
Background: Environmental exposure chambers have been used to expose subjects to aeroallergens to investigate the efficacy of prophylactic treatment with symptomatic agents in Japan.
Kazuhiro Hashiguchi, Ken-ichiro Wakabayashi, Michinori Togawa, Akihiro Saito, Kimihiro Okubo   +4 more
doaj   +2 more sources

Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar–specific ASIT

Allergology International, 2018
Background: About one-third of the Japanese population suffers from Japanese cedar pollinosis, which is frequently accompanied by Japanese cypress pollinosis. Recently, a novel major Japanese cypress pollen allergen, Cha o 3, was discovered.
Toshihiro Osada, Yuki Tanaka, Akira Yamada, Eiji Sasaki, Teruhiro Utsugi   +4 more
doaj   +2 more sources

Measurement of Japanese Cedar Pollen-Specific IgE in Nasal Secretions [PDF]

Allergology International, 2014
Background: : Japanese cedar pollen (JCP) is the most common allergen for seasonal allergic rhinitis in Japan. Little is known about local production of immunoglobulin (Ig)E in people with or without Japanese cedar pollinosis. The aims of this study were
Hiroshi Sakaida, Sawako Masuda, Kazuhiko Takeuchi   +2 more
doaj   +2 more sources

Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: A prospective, randomized, open-label study [PDF]

Allergology International, 2015
Background: Short-term oral immunotherapy (OIT) using the Cry j1-galactomannan conjugate for Japanese cedar pollinosis may be effective and relatively safe. However, a treatment regimen has not been established.
Daisuke Murakami, Motohiro Sawatsubashi, Sayaka Kikkawa, Masayoshi Ejima, Akira Saito, Akio Kato, Shizuo Komune   +6 more
doaj   +2 more sources

Analysis of Helper T Cell Responses to Cry j 1-Derived Peptides in Patients with Nasal Allergy: Candidate for Peptide-Based Immunotherapy of Japanese Cedar Pollinosis [PDF]

Allergology International, 2009
Background: Allergen specific immunotherapy is highly effective, but adverse events may occur during treatment. Peptide-based immunotherapy has been proposed as one of new strategies for reduction of allergic adverse reactions.
Keisuke Masuyama, Kazuaki Chikamatsu, Shuji Ikagawa, Tomokazu Matsuoka, Goro Takahashi, Takanori Yamamoto, Shuichiro Endo   +6 more
doaj   +2 more sources

Early Interventional Treatment with Intranasal Mometasone Furoate in Japanese Cedar/Cypress Pollinosis: A Randomized Placebo-Controlled Trial [PDF]

Allergology International, 2012
Background: Little is known about the safety and effectiveness of early interventional treatment (EIT) with intranasal corticosteroids for seasonal allergic rhinitis.
Seiichiro Makihara, Mitsuhiro Okano, Tazuko Fujiwara, Masayo Kimura, Takaya Higaki, Takenori Haruna, Yohei Noda, Kengo Kanai, Shin Kariya, Kazunori Nishizaki   +9 more
doaj   +2 more sources